Subscribe for discounted product + free Express delivery — Show Now!

No products in the cart.

Retatrutide 20mg Pen UK | Refillable Research Peptide Pen

Price range: £150.00 through £195.00

NOTE: One pen contains four doses, so a pen lasts for 4 weeks.

  • Free next-day UK delivery
  • International shipping available
  • Tested using high-performance liquid chromatography (HPLC)
  • 99.55% pure
  • Appetite suppressant
  • Available in 5 mg and 10 mg vials
  • 40 mg pen
  • Purity report: PDF download

All UK orders include:

  • 10 sterile syringes
  • 10 isopropyl alcohol wipes at 70 percent concentration

The syringes and alcohol wipes are complimentary and can be sent within the UK. and Customers outside the UK

The Retatrutide 20mg Pen is a research-grade, pre-filled refillable pen containing a triple GIP/GLP-1/glucagon receptor agonist peptide. Available in 10mg, 15mg, and 20mg. UK-dispatched

*MRP (inclusive of all taxes). More information

Retatrutide 20mg Pen UK — Research-Grade Triple Receptor Agonist Peptide

⚠️ Research Use Only. This product is not approved for human or veterinary use. It is intended strictly for laboratory and scientific research purposes. Not for self-administration.

The Retatrutide 20mg Pen is a pre-filled, refillable research peptide pen available to buy in the UK from WeightLossPeptides. It contains Retatrutide — a next-generation triple GIP/GLP-1/glucagon receptor agonist — at research-grade purity of ≥98% (HPLC verified). Available in three strengths — 10mg, 15mg, and 20mg — with fast UK dispatch and a Certificate of Analysis (COA) included with every order.


Choose Your Strength — 10mg, 15mg, or 20mg

This product is available in three variants to suit different research protocol requirements. Select your preferred strength before adding to cart.

Variant Strength Best For
Retatrutide Pen — 10mg 10mg Initial-phase or lower-dose research protocols
Retatrutide Pen — 15mg 15mg Mid-range protocols requiring moderate exposure
Retatrutide Pen — 20mg 20mg Advanced metabolic research requiring higher sustained dosing

All three variants are supplied as sterile, pre-filled refillable pens with ≥98% purity (HPLC), a Certificate of Analysis, and full reconstitution documentation.


What Is the Retatrutide 20mg Pen?

The Retatrutide 20mg Pen contains Retatrutide (LY3437943), a 39-amino acid synthetic peptide and modified analog of oxyntomodulin. It is classified as a triple hormone receptor agonist, simultaneously targeting GIP, GLP-1, and glucagon receptors.

Key product specifications:

  • Synonyms: LY3437943, GLP-1/GIP/Glucagon Triagonist
  • CAS Number: 2381089-83-2
  • Molecular Weight: ~4867.3 Da
  • Sequence: 39-amino acid peptide
  • Form: Pre-filled refillable injectable pen
  • Purity: ≥98% (HPLC verified)
  • Half-life: ~6–7 days (supports once-weekly administration)
  • Storage: Refrigerate at 2–8°C, protect from light
  • Use: Research use only

The refillable pen design means researchers only need to purchase replacement cartridges when a refill is required — reducing cost and maintaining convenience across extended research protocols.


How Does Retatrutide Work? — Mechanism of Action

Retatrutide works by simultaneously activating three hormone receptors involved in metabolic regulation. This triple-receptor approach produces a synergistic effect that is more comprehensive than single or dual receptor agonists.

GLP-1 Receptor Activation

Activating the GLP-1 receptor enhances insulin secretion in response to glucose, delays gastric emptying, and reduces appetite signalling. This is the same receptor targeted by Semaglutide and other GLP-1 agonist peptides currently under research investigation.

GIP Receptor Activation

GIP receptor activation improves insulin sensitivity and supports beta-cell function. Combined with GLP-1 receptor activation, this dual incretin effect creates a more robust glycaemic response than either pathway alone.

Glucagon Receptor Activation

Activating the glucagon receptor increases energy expenditure, promotes lipolysis (fat breakdown), and reduces hepatic fat accumulation. This component is unique to Retatrutide among currently researched peptides and is considered a key contributor to its observed weight reduction outcomes in published trials.

Together, these three mechanisms make Retatrutide a significant compound of interest in obesity, metabolic syndrome, and cardiometabolic research.


Retatrutide 20mg UK — Research Applications

The Retatrutide 20mg pen is used across a range of active research fields. Published and ongoing studies are investigating Retatrutide in the following areas:

  • Obesity and body weight regulation — In Phase 2 trials, high-dose Retatrutide produced up to 24.2% body weight reduction over 48 weeks
  • Type 2 diabetes and insulin resistance — Triple receptor activation produces favourable shifts in glycaemic and lipid marker
  • Non-alcoholic fatty liver disease (NAFLD) — Glucagon receptor activation supports reduction of hepatic fat accumulation
  • Cardiometabolic risk reduction — Improvements in lipid profiles and glucose metabolism observed across published data
  • Combination therapy research — Under investigation alongside amylin analogs such as Cagrilintide for enhanced metabolic outcomes

VLS Retatrutide 20mg Pen — What Researchers Need to Know

The VLS Retatrutide 20mg pen is a frequently searched format among UK research professionals. VLS refers to the pen delivery system format used for pre-filled research peptide administration. Our Retatrutide 20mg pen is supplied in this refillable pen format, offering consistent, measured delivery across research sessions.

The refillable design is a key advantage for extended research protocols. Rather than purchasing a complete new pen unit, researchers can purchase replacement cartridges — reducing cost per research cycle and maintaining delivery consistency throughout a study.


Dosing & Handling — Research Protocol Reference

The following information is provided as a research reference based on published trial data. It does not constitute medical advice or a protocol recommendation.

  • Formulation: Pre-filled refillable pen — 10mg, 15mg, or 20mg
  • Half-life: Approximately 6–7 days — supports once-weekly administration in research models
  • Administration route: Subcutaneous injection; rotate administration sites to minimise local irritation
  • Typical research cycle: 12–24 weeks for metabolic remodelling study parameters
  • Storage: Refrigerate at 2–8°C; protect from direct light; do not freeze
  • Reconstitution: Full reconstitution documentation included with every order
  • BAC Water: Required for reconstitution — available separately on our BAC Water product page

For volume-specific reconstitution guidance, refer to our Retatrutide Reconstitution Guide.


Storage & Packaging

All Retatrutide 20mg Pen orders are supplied as follows:

  • Sterile, pre-filled refillable pen in sealed, tamper-evident packaging
  • Refrigerate on arrival at 2–8°C
  • Do not freeze
  • Use aseptic technique throughout all research handling
  • Do not use if the seal has been compromised or the solution appears cloudy
  • Discreet, unmarked UK packaging — dispatched within 1–3 working days

Frequently Asked Questions — Retatrutide 20mg Pen UK

What is the Retatrutide 20mg Pen? It is a pre-filled refillable research peptide pen containing 20mg of Retatrutide — a triple GIP/GLP-1/glucagon receptor agonist peptide — at ≥98% purity. It is available to buy in the UK from WeightLossPeptides for research use only.

What strengths are available? The Retatrutide pen is available in three strengths: 10mg, 15mg, and 20mg. Select your preferred variant from the dropdown menu above before adding to cart.

What is the difference between 10mg, 15mg, and 20mg? The three variants differ in peptide concentration per pen. The 10mg is suited to lower-dose initial protocols. The 15mg suits mid-range study parameters. The 20mg is the preferred choice for advanced metabolic research requiring sustained higher-dose exposure over an extended research cycle.

What is the VLS Retatrutide 20mg Pen? VLS refers to the pen delivery system format used for pre-filled research peptide administration. Our Retatrutide 20mg pen is supplied in a refillable VLS-style pen format with replacement cartridges available separately.

Do I need BAC Water for the Retatrutide 20mg Pen? Yes. BAC Water is required for reconstitution before research use. We stock research-grade BAC Water in 3ml to 10ml sizes — view our BAC Water product page to add it to your order.

How is the Retatrutide 20mg Pen stored? Store refrigerated at 2–8°C before and after reconstitution. Protect from direct light. Do not freeze. Full storage guidance is included with your order.

Is the Retatrutide 20mg Pen legal to buy in the UK? Yes. Retatrutide is available as a research peptide in the UK for laboratory and scientific research use. It is not classified as a controlled substance. It is not licensed for human use and must not be self-administered.

How quickly will my order arrive? Orders placed before 2pm on working days are dispatched the same day. Standard UK delivery takes 1–2 working days in discreet, unmarked packaging.


Buy the Retatrutide 20mg Pen UK — Order Today

The Retatrutide 20mg Pen is in stock and available for fast UK dispatch. Select your strength — 10mg, 15mg, or 20mg — using the variant selector above and add to cart. A Certificate of Analysis and full reconstitution documentation are included with every order.

Need BAC Water for reconstitution? Add it to your order from our BAC Water product page.

Have a question? Contact our team before ordering and we will assist you in selecting the correct variant for your research protocol.

⚠️ This product is supplied strictly for research and laboratory use only. It is not intended for human consumption, medical use, or self-administration. By purchasing, you confirm you are a qualified research professional acquiring this product for legitimate scientific research purposes only.

Review Rating

Reviews

There are no reviews yet

Be the first to review “Retatrutide 20mg Pen UK | Refillable Research Peptide Pen”

Your email address will not be published. Required fields are marked